Efficacy and Pharmacogenomics of Cladribine Based Salvage Chemotherapy in Patients With Relapse/Refractory and Secondary Acute Myeloid Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
Medical College of Wisconsin
Medical College of Wisconsin
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Incyte Corporation
TC Biopharm
Institut Curie
OHSU Knight Cancer Institute
Roswell Park Cancer Institute
Weill Medical College of Cornell University
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
LEO Pharma
Gruppo Italiano Malattie EMatologiche dell'Adulto
Fred Hutchinson Cancer Center
Ensoma
Mayo Clinic
M.D. Anderson Cancer Center
Loyola University
Incyte Corporation
Mayo Clinic
Weill Medical College of Cornell University
GWT-TUD GmbH
Cellphire Therapeutics, Inc.
Duke University
University of Michigan Rogel Cancer Center
Fred Hutchinson Cancer Center
Dana-Farber Cancer Institute
University of Utah
Wake Forest University Health Sciences
Memorial Sloan Kettering Cancer Center
Hoffmann-La Roche
Incyte Corporation
Institut Bergonié
University of Liege
Novartis
Novartis
University of Chicago
CTI BioPharma
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
University of Oklahoma
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
NYU Langone Health
Masonic Cancer Center, University of Minnesota
Mayo Clinic
Sierra Oncology LLC - a GSK company
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota